Lopressor: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 12: Line 12:


===[[Lopressor adult dosing#FDA-Labeled Indications|FDA-Labeled Indications (Adult)]]===
===[[Lopressor adult dosing#FDA-Labeled Indications|FDA-Labeled Indications (Adult)]]===


===[[Lopressor adult dosing#Off-Label Use|Off-Label Use (Adult)]]===
===[[Lopressor adult dosing#Off-Label Use|Off-Label Use (Adult)]]===

Revision as of 15:02, 17 March 2014

Metoprolol
Clinical data
Trade namesLopressor, Toprol-xl
AHFS/Drugs.comMonograph
MedlinePlusa682864
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • AU: C
  • US: C (Risk not ruled out)
Routes of
administration
Oral, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability12%
MetabolismHepatic via CYP2D6, CYP3A4
Elimination half-life3-7 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H25NO3
Molar mass267.364 g/mol
3D model (JSmol)
Melting point120 °C (248 °F)
  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For information about metoprolol, click here.

Disclaimer

Black Box Warning

Adult Dosing

FDA-Labeled Indications (Adult)

Off-Label Use (Adult)

Pediatric Dosing

FDA-Labeled Indications (Pediatric)

Off-Label Use (Pediatric)

Dose Adjustments

FDA-Labeled Indications

Off-Label Use

Dosage Forms and Strengths

Indications and Usage

Contraindications

Warnings and Precautions

Adverse Reactions

Drug Interactions

Use in Specific Populations

Overdosage

Description

Mechanism of Action

Clinical Pharmacology

Nonclinical Toxicology

Clinical Studies

How Supplied/Storage and Handling

Patient Counseling Information

Labels and Packages

Pill Images and Characteristics

Price